Primary relevance to vitamin D Vitamin D is a stated subject of this paper.
Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.
Why this paper is included
Supporting source evidence:
We did not find any cross-sectional associations (p > 0.05) between baseline 25(OH)D levels and Aβ in any of the brain regions studied.
Source: Abstract. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Secondary analysis.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
This is a secondary analysis of the Multidomain Alzheimer Preventive Trial.
Source: Abstract.
Participants were 178 dementia-free individuals aged 70 years or older with data on plasma 25(OH)D and cerebral Aβ load assessed by [18F]-florbetapir positron emission tomography.
Source: Abstract.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Cross-sectional associations of plasma vitamin D with cerebral β-amyloid in older adults at risk of dementia
Secondary analysis · Alzheimer's Research & Therapy · 2018
Original publication title
Cross-sectional associations of plasma vitamin D with cerebral β-amyloid in older adults at risk of dementia
© The Author(s). 2018
Original publication · Publisher record · CC BY 4.0 · CC0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What background does the paper provide?
Vitamin D deficiency is associated with an increased risk of Alzheimer’s disease and increased beta-amyloid (Aβ) in animals. Hence we sought to investigate the relationship between plasma 25-hydroxyvitamin D (25(OH)D) and cerebral Aβ in older adults with subjective memory complaints.
Source: BackgroundAbstract: What methods does the paper describe?
This is a secondary analysis of the Multidomain Alzheimer Preventive Trial. Participants were 178 dementia-free individuals aged 70 years or older with data on plasma 25(OH)D and cerebral Aβ load assessed by [18F]-florbetapir positron emission tomography. Plasma 25(OH)D was measured at study baseline using a commercially available electro-chemiluminescence competitive binding assay. Standard uptake value ratios (SUVRs) were generated using the cerebellum as a reference. Brain regions assessed included the cortex, anterior cingulate, anterior putamen, caudate, hippocampus, medial orbitofrontal cortex, occipital cortex, parietal cortex, pons, posterior cingulate, posterior putamen, precuneus, semioval centre and temporal cortex.
Associations were explored using fully adjusted multiple linear regression models.
Source: MethodsAbstract: Results
Participants had a mean (SD) age of 76.2 years (4.4) and 59.6% were female. The mean (SD) plasma 25(OH)D level was 22.4 ng/ml (10.8) and the mean (SD) cortical SUVR was 1.2 (0.2). We did not find any cross-sectional associations (p > 0.05) between baseline 25(OH)D levels and Aβ in any of the brain regions studied.
Source: ResultsAbstract: Conclusions
These preliminary results suggest that circulating 25(OH)D is not associated with cerebral Aβ in older adults. Further longitudinal studies with the measurement of mid-life vitamin D status are required to explore the relationship between vitamin D and Aβ accrual over time, thereby circumventing the shortfalls of a cross-sectional study.
Source: ConclusionsAuthors’ abstract
Background
Vitamin D deficiency is associated with an increased risk of Alzheimer’s disease and increased beta-amyloid (Aβ) in animals. Hence we sought to investigate the relationship between plasma 25-hydroxyvitamin D (25(OH)D) and cerebral Aβ in older adults with subjective memory complaints.
Methods
This is a secondary analysis of the Multidomain Alzheimer Preventive Trial. Participants were 178 dementia-free individuals aged 70 years or older with data on plasma 25(OH)D and cerebral Aβ load assessed by [18F]-florbetapir positron emission tomography. Plasma 25(OH)D was measured at study baseline using a commercially available electro-chemiluminescence competitive binding assay. Standard uptake value ratios (SUVRs) were generated using the cerebellum as a reference. Brain regions assessed included the cortex, anterior cingulate, anterior putamen, caudate, hippocampus, medial orbitofrontal cortex, occipital cortex, parietal cortex, pons, posterior cingulate, posterior putamen, precuneus, semioval centre and temporal cortex.
Associations were explored using fully adjusted multiple linear regression models.
Results
Participants had a mean (SD) age of 76.2 years (4.4) and 59.6% were female. The mean (SD) plasma 25(OH)D level was 22.4 ng/ml (10.8) and the mean (SD) cortical SUVR was 1.2 (0.2). We did not find any cross-sectional associations (p > 0.05) between baseline 25(OH)D levels and Aβ in any of the brain regions studied.
Conclusions
These preliminary results suggest that circulating 25(OH)D is not associated with cerebral Aβ in older adults. Further longitudinal studies with the measurement of mid-life vitamin D status are required to explore the relationship between vitamin D and Aβ accrual over time, thereby circumventing the shortfalls of a cross-sectional study.
Publication and source details
Original title: Cross-sectional associations of plasma vitamin D with cerebral β-amyloid in older adults at risk of dementia
Fati Nourhashemi; Claudie Hooper; Christelle Cantet; Catherine Féart; Isabelle Gennero; Pierre Payoux; Anne Sophie Salabert; Sophie Guyonnet; Philipe De Souto Barreto; Bruno Vellas; for the Multidomain Alzheimer Preventive Trial/Data sharing Alzheimer (DSA) study groupVellasBrunoGuyonnetSophieCarriéIsabelleBrigitteLauréaneFaisantCatherineLalaFrançoiseDelrieuJulienVillarsHélèneCombrouzeEmelineBadufleCaroleZuerasAudreyAndrieuSandrineCantetChristelleMorinChristopheVan KanGabor AbellanDupuyCharlotteRollandYvesCaillaudCélineOussetPierre-JeanLalaFrançoiseFougèreBertrandWillisSherryBellevilleSylvieGilbertBrigitteFontaineFrancineDartiguesJean-FrançoisMarcetIsabelleDelvaFleurFoubertAlexandraCerdaSandrineMarie-Noëlle-CuffiCostesCorinneRouaudOlivierManckoundiaPatrickQuipourtValérieMarilierSophieFranonEvelyneBoriesLawrencePaderMarie-LaureBassetMarie-FranceLapoujadeBrunoFaureValérieTongMichael Li YungMalick-LoiseauChristineCazaban-CampistronEvelyneDesclauxFrançoiseBlatgeColetteDantoineThierryLaubarie-MouretCécileSaulnierIsabelleClémentJean-PierrePicatMarie-AgnèsBernard-BourzeixLaurenceWilleboisStéphanieDésormaisIléanaCardinaudNoëlleBonnefoyMarcLivetPierreRebaudetPascaleGédéonClaireBurdetCatherineTerracolFlavienPesceAlainRothStéphanieChaillouSylvieLouchartSandrineSudresKristelleLebrunNicolasBarro-BelayguesNadègeTouchonJacquesBennysKarimGabelleAudreyRomanoAuréliaTouatiLyndaMarelliCéciliaPaysCécileRobertPhilippeLe DuffFranckGervaisClaireGonfrierSébastienGasnierYannickBordesSergeBegorreDanièleCarpuatChristianKhalesKhaledLefebvreJean-FrançoisEl IdrissiSamira MisbahSkolilPierreSallesJean-PierreDufouilCaroleLehéricyStéphaneChupinMarieManginJean-FrançoisBouhayiaAliAllardMichèleRicolfiFrédéricDuboisDominiqueMartelMarie Paule BonceourCottonFrançoisBonaféAlainChanaletStéphaneHugonFrançoiseBonnevilleFabriceCognardChristopheCholletFrançoisPayouxPierreVoisinThierryDelrieuJulienPeifferSophieHitzelAnneAllardMichèleZancaMichelMonteilJacquesDarcourtJacquesMolinierLaurentDerumeauxHélèneCostaNadègeVincentChristianPerretBertrandVinelClaireOlivier-AbbalPascaleAndrieuSandrineCantetChristelleColeyNicola
Alzheimer's Research & Therapy · 2018
© The Author(s). 2018https://creativecommons.org/licenses/by/4.0/Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.Gérontopôle of ToulouseFrench Ministry of Health (PHRC 2008, 2009)Pierre Fabre Research Institute Exhonit Therapeutics SAAvid Radiopharmaceuticals Inc French National Agency for Research n°ANR-11-LABX-0018-01Vellas BrunoRepository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T16:17:31.185000+00:00
DOI: 10.1186/s13195-018-0371-1 · PMC5922310